GREY:TBPMQ - Post by User
Post by
Golddetectoron Jan 12, 2022 7:22pm
181 Views
Post# 34310753
Pharma not cannabis
Pharma not cannabis This hitting a 52 week low ahead of phase II fda results do not make a lot of sense to me. At mc 40M us while phase II drug is more than 10 times of that not considering ard003 or Reduvo. Mc is more like early stage pharma at preclinical stage not even into phase I.
main reason imo is ppl considering this as cannabis stock for whatever reason. However, the recent pullback is mainly due overreacted to bad financing done in December. However, 13 million shares cannot have that much impact. Even most of shorts coved above 13 or 14cents. Short volume reduced by 65% last two weeks tells something. Even after covid sp was not at this level. We did not even have phase 2 on at that time. Massively oversold imo. I bought more at 11.5c and planning to add more.